Skip to main content

Table 1 Comparison of baseline data, hematological parameters and coronary angiography data between elevated RBG group and control group

From: Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction

Variables Elevated RBG group (n = 265) Control group(n = 693) P value
Gender(man) 193 (72.8%) 551 (79.5%) 0.026*
Age 64.08 ± 12.94 61.64 ± 13.47 0.019*
Height(cm) 166.71 ± 7.44 166.78 ± 7.54 0.92
Weight(kg) 68.55 ± 12.18 68.76 ± 11.38 0.844
BMI(kg/m2) 24.93 ± 3.87 24.44 ± 3.53 0.132
SBP(mmHg) 124.80 ± 24.80 126.52 ± 20.83 0.315
DBP(mmHg) 76.14 ± 16.29 76.98 ± 14.32 0.472
Hypertension 167 (63.0%) 384 (55.4%) 0.033*
Diabetes 174 (65.7%) 88 (12.7%) < 0.001*
Previous MI 12 (4.5%) 10 (1.4%) 0.013*
Cerebral infarction 37 (14.0%) 65 (9.4%) 0.040*
CKD 30 (11.3%) 49 (7.1%) 0.032*
Smoking 119 (44.9%) 380 (54.8%) 0.006*
Killip grade
 I grade 158 (59.6%) 502 (72.4%) < 0.001*
 II grade 42 (15.8%) 112 (16.1%) 0.906
 III grade 2 (0.8%) 9 (1.3%) 0.480
 IV grade 63 (23.8%) 70 (10.1%) < 0.001*
TNI P50(P25-P75)(ng/ml) 17.9 (3.2–25) 14 (3.53–25) 0.286
Myo P50(P25-P75) (ng/ml) 500 (241–900) 500 (239–900) 0.096
CK-MB P50(P25-P75)(ng/ml) 80 (26.9–292) 80 (44–303.25) 0.406
BNP P50(P25-P75) (pg/ml) 216.5 (55.9–862) 134 (43.3–393.25) 0.002*
WBC (*10^9/L) 12.46 ± 4.61 11.19 ± 3.68 < 0.001*
Hb (g/L) 133.21 ± 23.15 135.99 ± 20.71 0.098
PLT (*10^9/L) 207.48 (146.4–289.3) 204.68 (130.5–275.2) 0.564
RBG(mmol/L) 16.34 (13.2–20.6) 7.35 (6.8–9.6) < 0.001*
ALT P50(P25-P75)IU/L) 53 (34–82) 44 (30–68.75) 0.001*
AST P50(P25-P75) (IU/L) 174.5 (79–323) 157.5 (76.75–262.25) 0.073
Scr P50(P25-P75) (μmol/L) 81 (71–105.5) 80.5 (69–92) 0.1
eGFR P50(P25-P75)
(ml/min/1.73m2)
77.18 (54.95–96.24) 82.37 (68.89–97.27) 0.022*
UA(μmol/L) 364.18 (318.3–468.6) 366.75 (314.6–453.3) 0.079
FBG(mmoL/L) 12.00 ± 5.47 6.45 ± 2.02 < 0.001*
TG(mmoL/L) 2.12 (1.68–3.39) 1.67 (1.32–2.87) 0.004*
TC(mmoL/L) 4.27 (3.03–5.97) 4.48 (2.97–5.42) 0.044*
HDL-c(mmoL/L) 1.02 (0.82–1.88) 1.13 (1.01–1.96) < 0.001*
LDL-c(mmoL/L) 2.62 (2.38–3.42) 2.80 (2.07–3.36) 0.017*
LVEF (%) 0.54 ± 0.12 0.58 ± 0.11 < 0.0010*
Aspirin 263 (99.2%) 681 (98.3%) 0.26
Clopidogrel 21 (7.9%) 95 (13.7%) 0.014*
Ticagrelor 244(%) 598 (86.3%) 0.014*
ACEI/ARB 112 (92.1%) 370 (53.4%) 0.002*
β-blocker 214 (80.8%) 580 (83.7%) 0.28
Statin 265 (100%) 688 (99.3%) 0.166
CCB 16 (6.0%) 44 (6.3%) 0.338
Furosemide 72 (27.1%) 177 (25.8%) 0.424
Antisterone 70 (26.4%) 179(%) 0.261
IABP 28 (10.6%) 35 (5.1%) 0.002*
CABG 5 (1.9%) 8 (1.2%) 0.381
Coronary lesions
 Single vessel lesion 44 (16.6%) 192 (27.7%) < 0.001*
 Double vessel lesions 95 (35.8%) 191 (27.6%) 0.012*
 Triple vessel lesions 126 (47.5%) 310 (44.7%) 0.434
Number of stents
 Single stent 167 (63.0%) 415 (59.9%) 0.374
 Two or more stents 44 (5.3%) 133 (19.2%) 0.356
 Left main lesion 37 (14.0%) 62 (9.0%) 0.023*
  1. BMI Body Mass Index, SBP Systolic blood pressure, DBP Diastolic blood pressure, CKD Chronic kidney diseases, TNI Troponin, Myo Myohemoglobin, CK-MB Creatine Kinase-MB, BNP Brain natriuretic peptide, WBC White blood cell, Hb Hemoglobin, PLT Platelet, RBG Random blood glucose, ALT Alanine transaminase, AST Aspartate transaminase, Scr Serum creatinine, eGFR Estimated glomerular filtration rate, UA Uric Acid, FBG Fasting blood glucose, TG Triglyceride, TC Total cholesterol, HDL-c High density lipoprotein-cholesterol, LDL-c Low density lipoproten-cholesterol, LVEF Left ventricular ejection fraction, CCB Calcium channel blocker, IABP Intra-aortic ballon pump, CABG Coronary Artery Bypass Grafting